Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myfortic in Non-infectious Intermediate Uveitis
NCT01092533Phase 3Completed
- Sponsor
- STZ eyetrial
- Start
- Mar 2010
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mycophenolate sodium in intermediate uveitis (IU) (2 arms), sponsored by STZ eyetrial. Primary endpoint: Time from study entry to first relapse at 6 months. Started Mar 2010; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
intermediate uveitis (IU)
Beyond the preview
Go deeper on NCT01092533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01092533.